Compounded tirzepatide
Sold by Coby Health · every compounded tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$239
| Medication · Monthly, month 1 at 2.5 mg | $239 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Monthly, month 1 at 2.5 mg “Starts at $299 $239 · Month 1 (2.5mg): $239 · Month 2 (5.0mg): $299 · Month 3 (7.5mg): $329 · Month 4 (10mg): $379 · Month 5+ (12.5mg): $439 · Month 6+ (15mg): $439” source, read August 31, 2026 | Per month$239 | Charged today$239 |
We earn nothing from this link. Coby Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
- August 31, 2026 — $239 · imported observation, no quote of ours
- September 2, 2026 — $239
- August 31, 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Not disclosed as of August 31, 2026 |
|---|---|
| States | All states except Arkansas, Louisiana, Mississippi, and New Mexico |
| Prescriber | Both |
| Cancellation | “Once a prescription is issued and sent to a pharmacy partner, the order cannot be changed. If you request an order cancellation prior to the order of any medication to a pharmacy partner, our team will take reasonable steps to cancel your order, but cancellations are not guaranteed. If cancellation is successful, a $50 non-refundable visit and clinical fee will be deducted from your refund.” |
| Consult fee | Not disclosed as of August 31, 2026 |
Not yet checked: membership.
Recorded from cobyhealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. August 31, 2026 — Coby Health's signup reaches an account-creation wall with a password field after three steps, before any medical history is collected. The prices in this record come from Coby's public treatment pages instead, so every figure has a URL behind it.
- 2. August 31, 2026 — Coby's fourteen discount badges are a mixed bag against its own monthly ladder: six exact, one floor claim that holds, two undersold in the reader's favor, and five overstated. Exact: semaglutide titration "save $200" ($677 − $477), "save $130" ($727 − $597), "save $120" ($747 − $627); tirzepatide titration "save $70" ($1,147 − $1,077), "save $90" ($1,257 − $1,167), "save $90" ($1,317 − $1,227). Holds as a floor claim: semaglutide "Save more than $400!" on a real $404. Understated in the reader's favor: semaglutide six-month titration "save $330" on a real $334 and "save $320" on a real $324. Overstated: semaglutide "Save more than $200!" on a real $188; semaglutide six-month titration "save $350" on a real $344; tirzepatide "Save $250!" on a real $170; tirzepatide "Save $600!" on a real $534; tirzepatide titration "save $100" on a real $80.
- 3. August 31, 2026 — The same-dose bundles, which carry no savings badge, all multiply exactly: three months at "0.25mg : $199 $115 /mo ($345)", "0.50mg : $199 $125 /mo ($375)", "1.0mg : $229 $160 /mo ($480)", "1.7mg : $249 $190 /mo ($570)", "2.4mg : $249 $219 /mo ($657)"; six months at $99, $115, $145, $174 and $199 a month for $594, $690, $870, $1,044 and $1,194.
- 4. August 31, 2026 — Coby Health's tirzepatide ladder climbs steadily with each dose increase, and it offers two prepaid bundles on top of it. The monthly ladder reads "Starts at $299 $239 · Month 1 (2.5mg): $239 · Month 2 (5.0mg): $299 · Month 3 (7.5mg): $329 · Month 4 (10mg): $379 · Month 5+ (12.5mg): $439 · Month 6+ (15mg): $439", alongside "First Quarter $947 $697 Save $250!" and "First 6 Months $2,204 $1,590 Save $600!"
- 5. August 31, 2026 — Coby's own FDA language, printed under every price block: "Compounded semaglutide is not reviewed or approved by the FDA for safety or effectiveness. Compounded semaglutide is not a generic form of Ozempic® or Wegovy®. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk. Coby Health has no affiliation with Novo Nordisk."
- 6. September 2, 2026 — On where it operates, the company's own wording is: “Currently, the Coby GLP-1 medication programs are available users in most states and metro areas (including Chicago , Los Angeles , and Phoenix ) except AR, LA, MS, and NM.” No list of served states appears, so none is recorded above.
1 further note concerns other Coby Health programs and sit on the provider record.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.